Literature DB >> 21883880

Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.

M M Aleman1, C Gardiner, P Harrison, A S Wolberg.   

Abstract

BACKGROUND: Microparticles (MPs) are sub-micron vesicles shed by activated or apoptotic cells, including platelets and monocytes. Increased circulating MPs are associated with thrombosis; however, their role in thrombogenesis is poorly understood.
OBJECTIVE: To determine how MPs promote thrombin generation and modulate fibrin density and stability.
METHODS: Platelets and monocytes were isolated from healthy donors. Platelets were stimulated with calcium ionophore, thrombin receptor agonist peptide (TRAP) or TRAP/convulxin. Monocytes and human monocytic THP-1 cells were stimulated with lipopolysaccharide (LPS). MPs were isolated, washed by high-speed centrifugation and assessed using the following: transmission electron microscopy (TEM), Nanoparticle Tracking Analysis (NTA), flow cytometry, tissue factor (TF) activity, prothrombinase activity, thrombin generation, and clot formation, density and stability.
RESULTS: MPs from monocytes (M-MPs) and platelets (PMPs) had similar shapes and diameters (100-300 nm). M-MPs had TF activity (16.7 ± 2.4 pm TF per 10(6) MP), supported prothrombinase activity and triggered shorter thrombin generation lag times than buffer controls (5.4 ± 0.5 vs. 84.2 ± 4.8 min, respectively). Compared with controls, M-MPs supported faster fibrin formation (0.24 ± 0.24 vs. 76.7 ± 15.1 mOD min(-1) , respectively), 38% higher fibrin network density and higher clot stability (3.8-fold higher turbidity in the presence of tissue plasminogen activator). In contrast, PMPs did not have TF activity and supported 2.8-fold lower prothrombinase activity than M-MPs. PMPs supported contact-dependent thrombin generation, but did not independently increase fibrin network density or stability. Interestingly, PMPs increased rates of thrombin generation and fibrin formation (1.7- and 1.3-fold, respectively) when mixed with THP-1-derived MPs.
CONCLUSION: MPs from platelets and monocytes differentially modulate clot formation, structure and stability, suggesting unique contributions to thrombosis.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883880      PMCID: PMC3206146          DOI: 10.1111/j.1538-7836.2011.04488.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

Review 1.  A cell-based model of hemostasis.

Authors:  M Hoffman; D M Monroe
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

2.  A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.

Authors:  J Ph Collet; G Montalescot; C Lesty; J W Weisel
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

3.  Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.

Authors:  Jeremiah C Boles; Julie C Williams; Rachel M Hollingsworth; Jian-Guo Wang; Sam L Glover; A Phillip Owens; David A Barcel; Raj S Kasthuri; Nigel S Key; Nigel Mackman
Journal:  Thromb Res       Date:  2011-07-16       Impact factor: 3.944

4.  Functional prothrombinase complex assembly on isolated monocytes and lymphocytes.

Authors:  P B Tracy; M S Rohrbach; K G Mann
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

5.  Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer.

Authors:  Shigenori Kanazawa; Shosaku Nomura; Midori Kuwana; Mikiko Muramatsu; Kazuyuki Yamaguchi; Shirou Fukuhara
Journal:  Lung Cancer       Date:  2003-02       Impact factor: 5.705

6.  Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.

Authors:  R J Berckmans; R Nieuwland; A N Böing; F P Romijn; C E Hack; A Sturk
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

7.  Effects of severe hypertension on endothelial and platelet microparticles.

Authors:  Richard A Preston; Wenche Jy; Joaquin J Jimenez; Lucia M Mauro; Lawrence L Horstman; Madelyn Valle; Gerard Aime; Yeon S Ahn
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

8.  Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs.

Authors:  Marina Camera; Marta Frigerio; Vincenzo Toschi; Marta Brambilla; Francesca Rossi; David C Cottell; Paola Maderna; Alessandro Parolari; Roberto Bonzi; Ombretta De Vincenti; Elena Tremoli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

9.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.

Authors:  Arun S Shet; Omer Aras; Kalpna Gupta; Mathew J Hass; Douglas J Rausch; Nabil Saba; Louann Koopmeiners; Nigel S Key; Robert P Hebbel
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  57 in total

1.  A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy.

Authors:  C R Krebs; Ling Li; Alisa S Wolberg; Amy L Oldenburg
Journal:  Rev Sci Instrum       Date:  2015-07       Impact factor: 1.523

2.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

Review 3.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

4.  Comparison of the size of membrane microparticles of different cellular origin by dynamic light scattering.

Authors:  I B Alchinova; S G Khaspekova; N V Golubeva; O N Shustova; O A Antonova; M Yu Karganov; A V Mazurov
Journal:  Dokl Biochem Biophys       Date:  2016-11-06       Impact factor: 0.788

Review 5.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

6.  Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Authors:  J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman
Journal:  J Thromb Haemost       Date:  2015-12-11       Impact factor: 5.824

7.  Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.

Authors:  Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Chase W Kessinger; Megan Elfline; Cathy Luke; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

8.  Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Authors:  Jeffrey I Zwicker; Howard A Liebman; Kenneth A Bauer; Thomas Caughey; Federico Campigotto; Rachel Rosovsky; Simon Mantha; Craig M Kessler; Jonathan Eneman; Vidya Raghavan; Heinz-Joseph Lenz; Andrea Bullock; Elizabeth Buchbinder; Donna Neuberg; Bruce Furie
Journal:  Br J Haematol       Date:  2012-12-13       Impact factor: 6.998

Review 9.  New players in haemostasis and thrombosis.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Thromb Haemost       Date:  2014-02-27       Impact factor: 5.249

Review 10.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.